Phone app study to collect symptom reports in NET
Part of Cancer clinical trials.
This study tests a mobile phone app that helps people with neuroendocrine tumors (NETs) report symptoms and quality of life. It may help by making it easier to track how you’re doing during treatment using questionnaires.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of NET (neuroendocrine tumor)
- You are planning to start or continue NET treatment
- You are 18 years or older and can give informed consent
- You can understand the questionnaire language and complete the forms
- You’re expected to live at least 6 months
- You have access to a smartphone or similar device to use the app
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a smartphone app to track your symptoms during radiation treatment for head and neck cancer. It aims to help your care team catch problems early and improve your quality of life.
This trial tests whether using a smartphone app to regularly report how you're feeling can help monitor your well-being during cancer treatment. If you're starting a new cancer treatment soon and are comfortable using a smartphone app, you may be able to join.
This trial tests if a smartphone app can help patients or caregivers perform a neurological exam at home. It aims to make check-ups easier for people with brain tumors.
This study follows people with advanced neuroendocrine tumors (NETs) that cannot be removed by surgery or have spread. Its goal is to see how long patients can live without having serious side effects from treatment, so doctors can better understand which treatments are worth the risks.
This study tests a smartphone app designed to help young adults who had cancer before age 25. The app aims to improve quality of life and support wellbeing during the years after treatment ends.
This study tests a mobile app designed to help people with cancer cope with their diagnosis and treatment. It may be a good fit if you have had cancer in the last two years and are comfortable using a smartphone app.
Hear when a new Neuroendocrine Neoplasms (Tumours) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.